AAAAAA

   
Results: 1-10 |
Results: 10
CORONARY-ARTERY DISEASE RISK FACTOR MODIFICATION - THE ROLE OF CORONARY CALCIUM SCREENING
Authors: FISHER BT HOFF JA CHOMKA EV KONDOS GT
Citation: Bt. Fisher et al., CORONARY-ARTERY DISEASE RISK FACTOR MODIFICATION - THE ROLE OF CORONARY CALCIUM SCREENING, Circulation, 98(17), 1998, pp. 3445-3445
CORONARY-ARTERY CALCIUM SCREENING BY ELECTRON-BEAM COMPUTED-TOMOGRAPHY - A 4 YEAR FOLLOW-UP FOR CORONARY EVENTS
Authors: SULLIVAN CJ FISHER BT BAGAI J CHOMKA EV DEVRIES SR HOFF JA KONDOS GT
Citation: Cj. Sullivan et al., CORONARY-ARTERY CALCIUM SCREENING BY ELECTRON-BEAM COMPUTED-TOMOGRAPHY - A 4 YEAR FOLLOW-UP FOR CORONARY EVENTS, Circulation, 98(17), 1998, pp. 3448-3448
RISK FACTOR CORRELATES FOR CORONARY-ARTERY CALCIUM USING ELECTRON-BEAM TOMOGRAPHY IN ASYMPTOMATIC MEN AND WOMEN
Authors: CHENG SC CHOMKA EV HOFF JA FREELS S KONDOS GT
Citation: Sc. Cheng et al., RISK FACTOR CORRELATES FOR CORONARY-ARTERY CALCIUM USING ELECTRON-BEAM TOMOGRAPHY IN ASYMPTOMATIC MEN AND WOMEN, Journal of the American College of Cardiology, 29(2), 1997, pp. 9267-9267
CAN CORONARY EVENTS BE PREDICTED IN ASYMPTOMATIC INDIVIDUALS USING ELECTRON-BEAM TOMOGRAPHY
Authors: HOFF JA WOLFKIEL CJ CHOMKA EV KONDOS GT
Citation: Ja. Hoff et al., CAN CORONARY EVENTS BE PREDICTED IN ASYMPTOMATIC INDIVIDUALS USING ELECTRON-BEAM TOMOGRAPHY, Circulation, 96(8), 1997, pp. 1382-1382
BLEEDING DURING ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL-FIBRILLATION
Authors: CHESEBRO JH WIEBERS DO HOLLAND AE BARDSLEY WT LITIN SC MEISSNER I ZERBE DM FLAKER GC WEBEL R NOLTE B STEVENSON P BYER J WRIGHT W ANDERSON DC ASINGER RW NEWBURG SM BUNDLIE SR FARMER CC KOLLER RL HAUGLAND JM NANCE MA TARREL RM DUNBAR DN JORGENSEN CR SHARKEY SW LEONARD AD KANTER MC SOLOMON DH ZABALGOITIA M MCANULTY JH MARCHANT C COULL BM KELLEY RE CHAHINE R PALERMO M TEIXEIRO P FELDMAN G HAYWARD A MACMILLAN K GANDARA E ANDERSON W BLANK N STRAUSS R FEINBERG WM VOLD BK KERN KB APPLETON C BRUCK D DORR S DITTRICH HC ROTHROCK JF HAGENHOFF C LOGAN WR HAMILTON WP GREEN BJ BACON RS HELGASON CM KONDOS GT HOFF J HALPERIN JL ROTHLAUF EB WEINBERGER JM GOLDMAN ME MILLER VT HOCKERSMITH CJ COHEN BA JANOSIK DL CADELL DJ KELLERMAN L GOMEZ CR LABOVITZ AJ ROTHBART RM BAILEY GH BURKHARDT C HORWITZ L BLACKSHEAR JL WEAVER L BAKER V LEE G LANE G RUBINO F SAFFORD R KRONMAL RA MCBRIDE R PEARCE L FLETCHER KA NASCO E HART RG SHERMAN DG TALBERT RL HEBERLING PA COLTON T LEVY DE MARSH JD WELCH KMA MARLER JR WALKER MD
Citation: Jh. Chesebro et al., BLEEDING DURING ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL-FIBRILLATION, Archives of internal medicine, 156(4), 1996, pp. 409-416
ABILITY OF THE NO-REFLOW PHENOMENON DURING AN ACUTE MYOCARDIAL-INFARCTION TO PREDICT LEFT-VENTRICULAR DYSFUNCTION AT ONE-MONTH FOLLOW-UP
Authors: KENNER MD ZAJAC EJ KONDOS GT DAVE R WINKELMANN JW JOFTUS J LAUCEVICIUS A KYBARSKIS A BERUKSTIS E URBONAS A FEINSTEIN SB
Citation: Md. Kenner et al., ABILITY OF THE NO-REFLOW PHENOMENON DURING AN ACUTE MYOCARDIAL-INFARCTION TO PREDICT LEFT-VENTRICULAR DYSFUNCTION AT ONE-MONTH FOLLOW-UP, The American journal of cardiology, 76(12), 1995, pp. 861-868
WARFARIN VERSUS ASPIRIN FOR PREVENTION OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION - STROKE PREVENTION IN ATRIAL-FIBRILLATION-II STUDY
Authors: MCBRIDE R CHESEBRO JH WIEBERS DO HOLLAND AE LINKER S BARDSLEY WT KOPECKY S LITIN SC MEISSNER I ZERBE DM FLAKER GC WEBEL R NOLTE B STEVENSON P BYER J JENKINS JS WRIGHT W ANDERSON DC ASINGER RW NEWBURG SM BUNDLIE SR FARMER CC KOLLER RL HAUGLAND JM NANCE MA TARREL RM DUNBAR DN JORGENSEN CR SHARKEY SW LEONARD ADS KANTER MC SOLOMON DH ZABALGOITIA M MCANULTY JH MARCHANT C COULL BM KELLEY RE CHAHINE R PALERMO M TEIXEIRO P FELDMAN G HAYWARD A MACMILLAN K GANDARA E ANDERSON W BLANK N STRAUSS R FEINBERG WM VOLD BK KERN KB APPLETON C BRUCK D DORR S DITTRICH HC ROTHROCK JF KERRIDGE C LOGAN WR HAMILTON WP GREEN BJ BACON RS HELGASON CM KONDOS GT HOFF J MCRAE RP HALPERIN JL ROTHLAUF EB WEINBERGER JM GOLDMAN ME MILLER VT HOCKERSMITH CJ COHEN BA JANOSIK DL CADELL DJ KELLERMAN L GOMEZ CR LABOVITZ AJ ROTHBART RM BAILEY GH BURKHARDT C HORWITZ L BLACKSHEAR JL WEAVER L BAKER V LEE G LANE G RUBINO F SAFFORD R KRONMAL RA PEARCE LA FLETCHER KA NASCO E HART RG SHERMAN DG TALBERT RL DACY TL HERBERLING PA
Citation: R. Mcbride et al., WARFARIN VERSUS ASPIRIN FOR PREVENTION OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION - STROKE PREVENTION IN ATRIAL-FIBRILLATION-II STUDY, Lancet, 343(8899), 1994, pp. 687-691
VARIABILITY IN PLASMA-LIPOPROTEIN PROFILES WHEN COMPARING DILTIAZEM AND PROPRANOLOL
Authors: LABRECHE DG KONDOS GT BARTELS DW BAUMAN JL
Citation: Dg. Labreche et al., VARIABILITY IN PLASMA-LIPOPROTEIN PROFILES WHEN COMPARING DILTIAZEM AND PROPRANOLOL, The Annals of pharmacotherapy, 27(9), 1993, pp. 1048-1052
ASPIRIN, WARFARIN, PLATELET-AGGREGATION STUDIES AND ATRIAL-FIBRILLATION
Authors: BRACE LD KONDOS GT HELAGSON CM
Citation: Ld. Brace et al., ASPIRIN, WARFARIN, PLATELET-AGGREGATION STUDIES AND ATRIAL-FIBRILLATION, Thrombosis and haemostasis, 69(6), 1993, pp. 632-632
PLATELET-AGGREGATION IN PATIENTS WITH ATRIAL-FIBRILLATION TAKING ASPIRIN OR WARFARIN
Authors: HELGASON CM HOFF JA KONDOS GT BRACE LD
Citation: Cm. Helgason et al., PLATELET-AGGREGATION IN PATIENTS WITH ATRIAL-FIBRILLATION TAKING ASPIRIN OR WARFARIN, Stroke, 24(10), 1993, pp. 1458-1461
Risultati: 1-10 |